Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activated protein kinase signalling pathway

Publisher: Spandidos Publications

E-ISSN: 1791-2431|33|2|840-848

ISSN: 1021-335X

Source: Oncology Reports, Vol.33, Iss.2, 2015-01, pp. : 840-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content